/
BAX
$21.38-$0.64 (-2.93%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$11.4B
516M shares
52-week range
$15.73 – $31.76
35% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NYSE
CS
Borrow rate
0.40%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-60.09
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.10B | $11.36B | $11.67B | $12.15B | $10.06B | $10.36B | $10.64B | $11.24B |
| Cost of revenue | $6.34B | $6.60B | $7.09B | $7.43B | $6.51B | $6.21B | $6.65B | $7.87B |
| Gross profit | $4.76B | $4.76B | $4.59B | $4.72B | $3.55B | $4.15B | $3.98B | $3.38B |
| Gross margin | 42.9% | 41.9% | 39.3% | 38.9% | 35.3% | 40.1% | 37.5% | 30.1% |
| R&D | $654.0M | $595.0M | $521.0M | $531.0M | $450.0M | $518.0M | $590.0M | $518.0M |
| Operating income | $1.58B | $1.77B | $1.62B | $1.35B | −$2.85B | $707.0M | $14.0M | −$308.0M |
| EBITDA | $2.48B | $1.87B | $2.27B | $2.19B | −$1.76B | $1.73B | $1.12B | $766.0M |
| Net income | $1.55B | $1.00B | $1.10B | $1.28B | −$2.43B | $2.66B | −$649.0M | −$957.0M |
| Net margin | 13.9% | 8.8% | 9.4% | 10.6% | -24.2% | 25.6% | -6.1% | -8.5% |
| EPS (diluted) | 2.97 | 1.93 | 2.13 | 2.53 | -4.83 | 5.23 | -1.27 | -1.75 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $11.4B | $1.92 | $1.85–$1.96 | 8 |
| 2027 | $11.6B | $1.99 | $1.90–$2.08 | 9 |
| 2028 | $11.9B | $2.15 | $1.99–$2.31 | 2 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
www.baxter.com- Employees
- 37,500
- IPO / List date
- May 15, 1961
- HQ
- DEERFIELD, IL
Held by traders on TradeandTell
No one on the platform currently holds BAX.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Bridgewater Associatesas of 2026-03-31 | 16,065 | $269.9K |
Insider activity (SEC Form 4)
Dividend history
TTM yield · 0.94% ($0.20/share)
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-29 | $0.0100 | 2026-07-01 |
| 2026-02-27 | $0.0100 | 2026-04-01 |
| 2025-11-28 | $0.0100 | 2026-01-02 |
| 2025-08-29 | $0.1700 | 2025-10-01 |
| 2025-05-30 | $0.1700 | 2025-07-01 |
| 2025-02-28 | $0.1700 | 2025-04-01 |
| 2024-11-29 | $0.1700 | 2025-01-02 |
| 2024-08-30 | $0.2900 | 2024-10-01 |
| 2024-05-31 | $0.2900 | 2024-07-01 |
| 2024-02-29 | $0.2900 | 2024-04-01 |
Recent trades on TradeandTell
No one on the platform has traded BAX yet.
